National Research Co. (NASDAQ:NRC – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $24.19 and last traded at $24.25, with a volume of 6962 shares traded. The stock had previously closed at $24.87.
National Research Trading Down 1.9 %
The firm has a market capitalization of $549.24 million, a P/E ratio of 18.55 and a beta of 0.56. The stock’s 50-day simple moving average is $29.70 and its two-hundred day simple moving average is $35.82. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.41 and a quick ratio of 0.41.
National Research (NASDAQ:NRC – Get Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter. The business had revenue of $35.31 million during the quarter. National Research had a net margin of 20.60% and a return on equity of 54.83%.
National Research Announces Dividend
Hedge Funds Weigh In On National Research
Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of National Research by 1.1% during the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after acquiring an additional 10,454 shares during the last quarter. Conestoga Capital Advisors LLC boosted its position in shares of National Research by 0.5% during the first quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company’s stock worth $31,080,000 after acquiring an additional 3,850 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of National Research by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after acquiring an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. bought a new position in shares of National Research during the third quarter worth $11,124,000. Finally, Comerica Bank bought a new position in shares of National Research during the third quarter worth $6,939,000. 47.26% of the stock is currently owned by institutional investors.
About National Research
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Stories
- Five stocks we like better than National Research
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Paychex Stock’s Dip is the Best Opportunity in Today’s Cycle
- What is a Bond Market Holiday? How to Invest and Trade
- Any Pullback in Tech May Signal a Rotation into These 3 Sectors
- Investing in Travel Stocks Benefits
- 3 Stocks to Watch: Oracle, Casey’s, FedEx Signal Big Gains
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.